• PCSK9 Inhibitor Improves Outcomes for Patients with Peripheral Artery Disease

    4 days ago - By BWH

    LDL-cholesterol-lowering drug evolocumab reduced risk of major cardiovascular events and major adverse limb events among peripheral artery disease sub-population from the FOURIER trial.
    Read more ...